Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 63

    1.

    Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment.

    Camara O, Jörke C, Hammer U, Egbe A, Rabenstein C, Runnebaum IB, Hoeffken K, Pachmann K.

    J Cancer Res Clin Oncol. 2009 Apr;135(4):643-7. Epub 2008 Oct 21.PMID: 18936973 [PubMed - indexed for MEDLINE]Related articles

    2.

    Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors.

    Gajda M, Camara O, Oppel S, Kroll T, Jörke C, Krauspe S, Hammer U, Rabenstein C, Untch M, Runnebaum IB, Pachmann K.

    Ann Oncol. 2008 Dec;19(12):2090-1. Epub 2008 Sep 26. No abstract available. PMID: 18820243 [PubMed - indexed for MEDLINE]Related articles

    3.

    Circulating tumor cells in breast cancer: methodology and clinical repercussions.

    Gasent Blesa JM, Alberola Candel V, Esteban González E, Vidal Martínez J, Gisbert Criado R, Provencio Pulla M, Laforga Canales J, Pachmann K.

    Clin Transl Oncol. 2008 Jul;10(7):399-406. Review.PMID: 18628068 [PubMed - indexed for MEDLINE]Related articles

    4.

    Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.

    Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U, Altendorf-Hofmann A, Rabenstein C, Pachmann U, Runnebaum I, Höffken K.

    J Clin Oncol. 2008 Mar 10;26(8):1208-15.PMID: 18323545 [PubMed - indexed for MEDLINE]Related articles

    5.

    The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer.

    Camara O, Rengsberger M, Egbe A, Koch A, Gajda M, Hammer U, Jörke C, Rabenstein C, Untch M, Pachmann K.

    Ann Oncol. 2007 Sep;18(9):1484-92.PMID: 17761704 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.

    Pachmann K, Dengler R, Lobodasch K, Fröhlich F, Kroll T, Rengsberger M, Schubert R, Pachmann U.

    J Cancer Res Clin Oncol. 2008 Jan;134(1):59-65. Epub 2007 Jul 5.PMID: 17611779 [PubMed - indexed for MEDLINE]Related articles

    7.

    Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapse.

    Lobodasch K, Fröhlich F, Rengsberger M, Schubert R, Dengler R, Pachmann U, Pachmann K.

    Breast. 2007 Apr;16(2):211-8. Epub 2007 Feb 8.PMID: 17291754 [PubMed - indexed for MEDLINE]Related articles

    8.

    Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion.

    Kuethe F, Krack A, Fritzenwanger M, Herzau M, Opfermann T, Pachmann K, Sayer HG, Werner GS, Gottschild D, Figulla HR.

    Pharmazie. 2006 Nov;61(11):957-61.PMID: 17152990 [PubMed - indexed for MEDLINE]Related articles

    9.

    Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells.

    Camara O, Kavallaris A, Nöschel H, Rengsberger M, Jörke C, Pachmann K.

    World J Surg Oncol. 2006 Sep 26;4:67.PMID: 17002789 [PubMed]Related articlesFree article

    10.

    Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells.

    Clement JH, Schwalbe M, Buske N, Wagner K, Schnabelrauch M, Görnert P, Kliche KO, Pachmann K, Weitschies W, Höffken K.

    J Cancer Res Clin Oncol. 2006 May;132(5):287-92. Epub 2006 Jan 24.PMID: 16432758 [PubMed - indexed for MEDLINE]Related articles

    11.

    Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring.

    Pachmann K, Camara O, Kavallaris A, Schneider U, Schünemann S, Höffken K.

    Breast Cancer Res. 2005;7(6):R975-9. Epub 2005 Oct 4.PMID: 16280045 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction.

    Kuethe F, Figulla HR, Herzau M, Voth M, Fritzenwanger M, Opfermann T, Pachmann K, Krack A, Sayer HG, Gottschild D, Werner GS.

    Am Heart J. 2005 Jul;150(1):115.PMID: 16086558 [PubMed - indexed for MEDLINE]Related articles

    13.

    Longtime recirculating tumor cells in breast cancer patients.

    Pachmann K.

    Clin Cancer Res. 2005 Aug 1;11(15):5657; author reply 5657-8. No abstract available. PMID: 16061886 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

    Pachmann K, Clement JH, Schneider CP, Willen B, Camara O, Pachmann U, Höffken K.

    Clin Chem Lab Med. 2005;43(6):617-27.PMID: 16006258 [PubMed - indexed for MEDLINE]Related articles

    15.

    Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report.

    Rolle A, Günzel R, Pachmann U, Willen B, Höffken K, Pachmann K.

    World J Surg Oncol. 2005 Mar 31;3(1):18.PMID: 15801980 [PubMed - as supplied by publisher]Related articlesFree article

    16.

    Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT.

    Scholl S, Mügge LO, Issa MC, Kasper C, Pachmann K, Höffken K, Sayer HG.

    Bone Marrow Transplant. 2005 Jan;35(2):183-90.PMID: 15531897 [PubMed - indexed for MEDLINE]Related articles

    17.

    Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC).

    Pachmann K, Heiss P, Demel U, Tilz G.

    Clin Chem Lab Med. 2001 Sep;39(9):811-7.PMID: 11601678 [PubMed - indexed for MEDLINE]Related articles

    18.

    Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification.

    Pachmann K, Zhao S, Schenk T, Kantarjian H, El-Naggar AK, Siciliano MJ, Guo JQ, Arlinghaus RB, Andreeff M.

    Br J Haematol. 2001 Mar;112(3):749-59.PMID: 11260080 [PubMed - indexed for MEDLINE]Related articles

    19.

    Complementary anchor PCR of rearranged variable T-cell receptor beta-chain cDNA regions.

    Oduncu F, Krause G, Röhnisch T, Emmerich B, Pachmann K.

    Biol Chem. 1997 Oct;378(10):1211-4. Review.PMID: 9372194 [PubMed - indexed for MEDLINE]Related articles

    20.

    Applications of consensus polymerase chain reaction with subsequent electrophoretic distinction of amplificates.

    Krause G, Oduncu F, Kaltstein A, Pusl T, Pachmann K, Gerzer R.

    Electrophoresis. 1997 Jun;18(7):1098-102.PMID: 9237562 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...